Bone Pain study: Quality-of-Life Assessment vs Radiation Therapy
Official title Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
ClinicalTrials.gov ID: NCT03858205
What this study is testing
- What it's testing
- This study is testing whether low‑dose radiation can reduce bone pain in people with multiple myeloma that has spread to bone.
- Who it's for
- You may be able to join if you have multiple myeloma that has spread to bone and you are experiencing bone pain.
- What's involved
- You will receive short courses of low‑dose radiation to the painful bone areas. You will have a few visits for the treatment and follow‑up checks.
- Time commitment
- The study lasts about a month, with a few treatment visits and later check‑ins to see how you feel.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Histologic diagnosis of multiple myeloma
- Painful bone metastasis (index lesion) that has a radiographic correlate
- Patient may have had any number of prior chemotherapy/immunotherapy regimens (changes to systemic therapy or use of bisphosphonates for 4 weeks...
- Eastern Cooperative Oncology Group (ECOG) 0-2
- Brief Pain Inventory (BPI) score \>= 2
You likely can't join if
- Patients will be ineligible if the index lesion has received prior radiation therapy or prior palliative surgery.
- Patients will also be ineligible if there is pathologic fracture or impending fracture at the site of the index lesion or planned surgical fixation...
- Patients with clinical or radiographic evidence of spinal cord or cauda equina compression/effacement from the index lesion, and/or with index...
- Patients must not be pregnant
See the full eligibility criteria
- Histologic diagnosis of multiple myeloma
- Painful bone metastasis (index lesion) that has a radiographic correlate
- Patient may have had any number of prior chemotherapy/immunotherapy regimens (changes to systemic therapy or use of bisphosphonates for 4 weeks before and after RT are allowed, but recording of these changes must be...
- Eastern Cooperative Oncology Group (ECOG) 0-2
- Brief Pain Inventory (BPI) score \>= 2
- Ability to understand and the willingness to sign a written informed consent
- Patients will be ineligible if the index lesion has received prior radiation therapy or prior palliative surgery.
- Patients will also be ineligible if there is pathologic fracture or impending fracture at the site of the index lesion or planned surgical fixation of the bone at the index lesion
- Patients with clinical or radiographic evidence of spinal cord or cauda equina compression/effacement from the index lesion, and/or with index lesions located at the skull base or orbital lesions
- Patients must not be pregnant
The study team makes the final eligibility decision.
Where it is enrolling
- Duarte, California, United States
- Los Angeles, California, United States
- Atlanta, Georgia, United States
- Boston, Massachusetts, United States
- Minneapolis, Minnesota, United States
- New York, New York, United States
- Philadelphia, Pennsylvania, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Duarte, California, United States; Los Angeles, California, United States; Atlanta, Georgia, United States; Boston, Massachusetts, United States; Minneapolis, Minnesota, United States; New York, New York, United States and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.